Shire Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SHIRE, and what generic and branded alternatives to SHIRE drugs are available?
SHIRE has twenty-four approved drugs.
Summary for Shire
US Patents: | 0 |
Tradenames: | 17 |
Ingredients: | 15 |
NDAs: | 24 |
Patent Litigation for Shire: | See patent lawsuits for Shire |
PTAB Cases with Shire as patent owner: | See PTAB cases with Shire as patent owner |
Drugs and US Patents for Shire
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shire | SUPPRELIN | histrelin acetate | INJECTABLE;INJECTION | 019836-003 | Dec 24, 1991 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Shire | SALUTENSIN-DEMI | hydroflumethiazide; reserpine | TABLET;ORAL | 012359-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Shire | ETHMOZINE | moricizine hydrochloride | TABLET;ORAL | 019753-003 | Jun 19, 1990 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Shire
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Shire | ETHMOZINE | moricizine hydrochloride | TABLET;ORAL | 019753-002 | Jun 19, 1990 | 3,864,487 | ⤷ Subscribe |
Shire | SUPPRELIN | histrelin acetate | INJECTABLE;INJECTION | 019836-001 | Dec 24, 1991 | 4,244,946 | ⤷ Subscribe |
Shire | ETHMOZINE | moricizine hydrochloride | TABLET;ORAL | 019753-002 | Jun 19, 1990 | 3,740,395 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.